OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Tofacitinib use in ulcerative colitis: An expert consensus for day-to-day clinical practice
Rupa Banerjee, Vishal Sharma, Rajendra Patel, et al.
Indian Journal of Gastroenterology (2024) Vol. 43, Iss. 1, pp. 22-35
Closed Access | Times Cited: 7
Rupa Banerjee, Vishal Sharma, Rajendra Patel, et al.
Indian Journal of Gastroenterology (2024) Vol. 43, Iss. 1, pp. 22-35
Closed Access | Times Cited: 7
Showing 7 citing articles:
Oral colon-targeted responsive chitosan/pectin-based nanoparticles propels the application of tofacitinib in colitis therapy
Chunfei Wu, Chuanlin Bi, Geun-soo Kim, et al.
Scientific Reports (2025) Vol. 15, Iss. 1
Open Access
Chunfei Wu, Chuanlin Bi, Geun-soo Kim, et al.
Scientific Reports (2025) Vol. 15, Iss. 1
Open Access
Assessment and management for latent tuberculosis before advanced therapies for immune-mediated inflammatory diseases: A comprehensive review
Daya Krishna Jha, Rinkal Kakadiya, Ananya Sharma, et al.
Autoimmunity Reviews (2025), pp. 103758-103758
Closed Access
Daya Krishna Jha, Rinkal Kakadiya, Ananya Sharma, et al.
Autoimmunity Reviews (2025), pp. 103758-103758
Closed Access
Janus kinase inhibitors in the management of acute severe ulcerative colitis: a comprehensive review
Javier P. Gisbert, María Chaparro
Journal of Crohn s and Colitis (2025) Vol. 19, Iss. 2
Closed Access
Javier P. Gisbert, María Chaparro
Journal of Crohn s and Colitis (2025) Vol. 19, Iss. 2
Closed Access
Comprehensive overview of novel chemical drugs for ulcerative colitis: focusing on phase 3 and beyond
Benedetto Neri, Roberto Mancone, Mariasofia Fiorillo, et al.
Expert Opinion on Pharmacotherapy (2024) Vol. 25, Iss. 5, pp. 485-499
Closed Access | Times Cited: 3
Benedetto Neri, Roberto Mancone, Mariasofia Fiorillo, et al.
Expert Opinion on Pharmacotherapy (2024) Vol. 25, Iss. 5, pp. 485-499
Closed Access | Times Cited: 3
Strategies for enhancing Inflammatory Bowel Disease care in Pakistan: Bridging gaps and building capacities
Jalpa Devi, Parakkal Deepak, Amna Subhan Butt
Crohn s & Colitis 360 (2024) Vol. 6, Iss. 2
Open Access | Times Cited: 2
Jalpa Devi, Parakkal Deepak, Amna Subhan Butt
Crohn s & Colitis 360 (2024) Vol. 6, Iss. 2
Open Access | Times Cited: 2
Tofacitinib-Induced Hepatitis and Tuberculosis: A Case of Two Rare Adverse Events in A Single Patient
Kamlesh Taori, Sanjay Kumar, Mayankbhushan Pateriya, et al.
Journal of Clinical and Experimental Hepatology (2024) Vol. 15, Iss. 2, pp. 102457-102457
Closed Access | Times Cited: 1
Kamlesh Taori, Sanjay Kumar, Mayankbhushan Pateriya, et al.
Journal of Clinical and Experimental Hepatology (2024) Vol. 15, Iss. 2, pp. 102457-102457
Closed Access | Times Cited: 1
Tofacitinib in the treatment of ulceral colitis: real-world clinical practice and prospects
Д. И. Трухан
Meditsinskiy sovet = Medical Council (2024), Iss. 15, pp. 200-208
Open Access
Д. И. Трухан
Meditsinskiy sovet = Medical Council (2024), Iss. 15, pp. 200-208
Open Access
